False positive rate = false positive false positive +
true negative
= 56 56+ 785
= 6.65% can be equalled to 6.7%
Option d) is the correct answer
Question 14 (1 point) The Table below illustrates a study conducted to determine the diagnostic value...
Question 15 (1 point) The Table below illustrates a study conducted to determine the diagnostic value of CA-125 in the diagnosis of ovarian cancer. CA-125 test results 212 ng/mL 212 ng/mL Patient Population Ovarian Cancer Healthy Population 6 65 785 56 From the above data, what is the sensitivity of the test? a) 91.5% b) 95.4 % c) 85.6 % d) 99.2 %
Question 16 (1 point) The Table belowillustrates a study conducted to determine the diagnostic value of CA-125 in the diagnosis of ovarian cancer. CA-125 test results Results greater than 212 ng/ml Results greater than 212 ng/ml Patient Population 6 65 Ovarian Cancer 56 785 Healthy population From the above data calculate the specificity of the test? a) 90.5 % b) 93.3 % c) 96.7 % d) 89.8 %
explaim the mechanisms amd toxological effects if type 1
diabetes in this article
Exposure to arsenic in drinking water is associated with increased prevalence of diabetes. We previously reported an association of diabetes and urinary concentration of dimethylarsinite (DMAS"), a toxic product of arsenic methylation by arsenic (+ 3 oxidation state) methyltransferase (AS3MT). Here we examine associations between AS3MT polymorphism, arsenic metabolism and diabetes. Fasting blood glucose, oral glucose tolerance and self-reported diagnoses were used to identify diabetic individuals. Inorganic...
Identify the scientific premise, main hypothesis addressed by
the paper and the research question of the paper
Also, what is the main results and the implication of
results
IMPORTANCE Clinical outcomes for glioblastoma remain poor. Treatment with immune checkpoint blockade has shown benefits in many cancer types. To our knowledge, data from a randomized phase 3 clinical trial evaluating a programmed death-1 (PD-1) inhibitor therapy for glioblastoma have not been reported. OBJECTIVE To determine whether single-agent PD-1 blockade with nivolumab...